About GSK Dividend Returns
GSK plc (GSK) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of GSK over the past year?
GSK plc (GSK) delivered a total return of 61.99% over the past year when dividends are reinvested. The price-only return was 57.30%, meaning dividends contributed an additional 4.68 percentage points to total returns.
Q2How much would $10,000 invested in GSK be worth today?
A $10,000 investment in GSK plc one year ago would be worth $16,199 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $15,730. Dividend reinvestment added $468 to the portfolio value.
Q3Does GSK pay dividends?
Yes, GSK plc (GSK) pays dividends. In the last year, GSK paid approximately $1.22 per share in dividends (2.77% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.
Q4Did GSK beat the S&P 500?
Yes, GSK plc (GSK) outperformed the S&P 500 by 46.54 percentage points over the past year. GSK delivered a total return of 61.99%, compared to the S&P 500's 15.45%. This 46.54pp alpha means investors in GSK earned more than a passive S&P 500 index fund.
Q5What is GSK's worst drawdown?
GSK plc (GSK) experienced a maximum drawdown of -16.81% over the past year, declining from its peak on 2025-03-18 to its trough on 2025-04-10. The stock recovered to its prior peak by 2025-05-30. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is GSK's long-term total return over 10, 20, or 30 years?
GSK plc (GSK) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 101.6% (7.3% CAGR) — $10,000 would have grown to $20,164. Over 20 years: 98.2% total return (3.5% CAGR) — $10,000 → $19,819. Over 30 years: 313.0% total return (4.8% CAGR) — $10,000 → $41,303. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was GSK's best and worst year?
GSK plc's best calendar year was 1997 with a total return of 52.6%. Its worst year was 2008 with a total return of -25.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 78.3 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).